Search Results for "Neupro"

15:35 EDT 24th May 2016 | BioPortfolio

Matching Channels


Matching News

BRIEF-UCB posts FY REBIT ahead of Reuters poll

* FY revenue and net sales increased driven by product growth: Cimzia, Vimpat, Neupro and Keppra combined reached net sales of 2.76 billion euros ($3.05 billion) (+29 pct); representing 77 pct of net...

Cimzia and epilepsy drugs fuel UCB growth

Strong performances from its flagship products have lifted revenues of specialist pharma company UCB.The Belgium-headquartered firm announced its 2015 results late last week, with reven...

Parkinson's Disease Market Will Exceed $3 Billion by 2021 Despite Little Advance Towards a Cure, Says GBI Research

LONDON, February 25, 2016 /PRNewswire/ -- A new report from business intelligence provider GBI Research - Parkinson's Disease Therapeutics in Major Developed Markets to 2021 - states that the Parkins...

Matching PubMed Articles


Search Whole site using Google

Quick Search
Advertisement Advertisement